» Articles » PMID: 24705102

Differential Effects of MicroRNAs on Glioblastoma Growth and Migration

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2014 Apr 8
PMID 24705102
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Glioblastoma multiforme is characterized by rapid proliferation, aggressive metastatic potential, and resistance to radio- and chemotherapy. The matricellular protein CYR61 regulates cellular proliferation and migration and is highly expressed in Glioblastomas. MicroRNAs are 22-nucleotides long RNAs that regulate gene expression post-transcriptionally. Here, we utilized the LN229 glioblastoma cell line and found that CYR61 is a target of miR-136, miR-155, and miR-634. Over-expression of miR-136 and miR-634 miRNAs negatively affected proliferation, but not migration, while expression of miR-155 reduced migration but did not affect the proliferation of LN229 cells. Investigation of the molecular mechanisms affected by expression of miR-634 revealed an increased phosphorylation of p70S6 kinase, suggesting an induction of the mammalian target of rapamycin (mTOR) complex 1 pathway. Additionally, in miR-634 overexpressing cells, TSC2, a negative regulator of mTOR signaling, was found to be decreased. Altogether, our study provides insights on the differential roles of miRs-136, -155, and -634 in regulating glioblastoma cell growth and migration, and how microRNAs could be manipulated to decrease the aggressiveness and metastatic potential of tumor cells.

Citing Articles

Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study.

Yang L, Niu Z, Ma Z, Wu X, Vong C, Li G Cancer Cell Int. 2024; 24(1):323.

PMID: 39334350 PMC: 11437892. DOI: 10.1186/s12935-024-03507-x.


Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression.

Mao Y, Liu Z, Cai L Oncol Lett. 2020; 20(2):1619-1628.

PMID: 32724403 PMC: 7377174. DOI: 10.3892/ol.2020.11729.


The Inhibition of MicroRNA-139-5p Promoted Osteoporosis of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Wnt/Beta-Catenin Signaling Pathway by NOTCH1.

Feng Y, Wan P, Yin L, Lou X J Microbiol Biotechnol. 2019; 30(3):448-458.

PMID: 31752063 PMC: 9728286. DOI: 10.4014/jmb.1908.08036.


Tumor suppressor microRNA-136-5p regulates the cellular function of renal cell carcinoma.

Chen P, Zhao L, Pan X, Jin L, Lin C, Xu W Oncol Lett. 2018; 15(4):5995-6002.

PMID: 29556316 PMC: 5844007. DOI: 10.3892/ol.2018.8081.


MiR-634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf-ERK signaling pathway.

Tan Z, Zhao J, Jiang Y Cancer Med. 2018; 7(3):913-921.

PMID: 29473317 PMC: 5852346. DOI: 10.1002/cam4.1351.


References
1.
Dai Y, Qiu Z, Diao Z, Shen L, Xue P, Sun H . MicroRNA-155 inhibits proliferation and migration of human extravillous trophoblast derived HTR-8/SVneo cells via down-regulating cyclin D1. Placenta. 2012; 33(10):824-9. DOI: 10.1016/j.placenta.2012.07.012. View

2.
Grabacka M, Placha W, Plonka P, Pajak S, Urbanska K, Laidler P . Inhibition of melanoma metastases by fenofibrate. Arch Dermatol Res. 2004; 296(2):54-8. DOI: 10.1007/s00403-004-0479-y. View

3.
Haque I, Mehta S, Majumder M, Dhar K, De A, McGregor D . Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Mol Cancer. 2011; 10:8. PMC: 3027193. DOI: 10.1186/1476-4598-10-8. View

4.
Ostling P, Leivonen S, Aakula A, Kohonen P, Makela R, Hagman Z . Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res. 2011; 71(5):1956-67. DOI: 10.1158/0008-5472.CAN-10-2421. View

5.
Furnari F, Huang H, Cavenee W . Genetics and malignant progression of human brain tumours. Cancer Surv. 1995; 25:233-75. View